Search Results - Prakash Ghosh

Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme by Md. Sakhawat Hossain, Amresh Kumar, A.F.M Akhtar Hossain, Md. Mahshin, Abhijit Sharma, Md. Akter Hossain, Varun Sharma, Rashidul Haque, A.K.M Shamsuzzaman, Shomik Maruf, Prakash Ghosh, Vivek Ahuja, Dinesh Mondal

Connect to this object online.

Dried Blood Spots (DBS): A suitable alternative to using whole blood samples for diagnostic testing of visceral leishmaniasis in the post-elimination era. by Prakash Ghosh, Rajashree Chowdhury, Md Abu Rahat, Faria Hossain, Nur E Arpha, Mojca Kristan, Matthew Higgins, Ahmed Abd El Wahed, Yasuyuki Goto, M M Towhidul Islam, Susana Campino, Mary Cameron, Malcom S Duthie, Rashidul Haque, Dinesh Mondal

Connect to this object online.

Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh by Shomik Maruf, Soumik Kha Sagar, Md Utba Rashid, Md Rasel Uddin, Debashis Ghosh, Prakash Ghosh, Rupen Nath, Abu Nayeem Mohammad Sohel, M.M. Aktaruzzaman, Md. Nazmul Islam, Megha Raj Banjara, Axel Kroeger, Abraham Aseffa, Dinesh Mondal

Connect to this object online.

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. by Shyam Sundar, Krishna Pandey, Dinesh Mondal, Major Madhukar, Roshan Kamal Topno, Ashish Kumar, Vinod Kumar, Deepak Kumar Verma, Jaya Chakravarty, Rahul Chaubey, Poonam Kumari, Md Utba Rashid, Shomik Maruf, Prakash Ghosh, Sheeraz Raja, Joelle Rode, Margriet den Boer, Pradeep Das, Jorge Alvar, Suman Rijal, Fabiana Alves

Connect to this object online.